The naked eye alone is not enough to ensure the accurate diagnosis of skin cancer, say experts

December 6, 2018, University of Birmingham

The visual inspection of a suspicious skin lesion using the naked eye alone is not enough to ensure the accurate diagnosis of skin cancer, a group of experts have concluded following a largescale systematic review of research.

The review is published today (Dec 6th) in The Cochrane Library as part of a Special Collection of Cochrane Systematic Reviews bringing together a large body of research on the accuracy of tests used to diagnose . The suite of eleven reviews was led by Dr. Jac Dinnes at the University of Birmingham and supported by the Cochrane Skin Group and a team of over 30 researchers and expert advisors. The work was funded by the National Institute for Health Research (NIHR).

The reviews summarise assessing the accuracy of different diagnostic tests to support clinical and policy related decision making in the diagnosis of all types of skin cancer.

Dr. Jac Dinnes, of the University of Birmingham's Institute of Applied Health Research, said: "Early and accurate detection of all skin cancer types is essential to manage the disease and to improve survival rates in melanoma, especially given the rate of skin cancer world-wide is rising.

"The visual nature of skin cancer means that it can be detected and treated in many different ways and by a number of different types of specialists, therefore the aim of these reviews is to provide the world's best evidence for how this endemic type of cancer should be identified and treated.

"We have found that careful consideration should be given of the technologies that could be used to make sure that skin cancers are not missed, at the same time ensuring that inappropriate referrals for specialist assessment and inappropriate excision of benign skin lesions are kept to a minimum."

There are three main forms of skin cancer. Melanoma and cutaneous squamous cell carcinoma (cSCC), are high-risk skin cancers with the potential to spread and cause death.

A basal cell carcinoma (BCC) rarely spreads, usually remaining localised with potential to infiltrate and damage surrounding tissue.

Key findings of the Special Collection were:

  • Visual inspection using the naked eye alone is not good enough and melanomas may be missed.
  • Smartphone applications used by people with concerns about new or changing moles or other skin lesions have a high chance of missing melanomas.
  • When used by specialists, dermoscopy—a technique using a handheld device to zoom in on a mole and the underlying skin—is better at diagnosing melanoma than visual inspection alone, and may also help in the diagnosis of BCCs.
  • Dermoscopy might also help GPs to correctly identify people with suspicious lesions who need to be seen by a specialist.
  • Dermoscopy is already widely used by dermatologists to diagnose melanoma but its use in primary care has not been widely evaluated therefore more specific research is needed.
  • Checklists to help interpret dermoscopy might improve the accuracy of diagnosis for practitioners with less expertise and training.
  • Teledermatology—remote specialist assessment of skin lesions using dermoscopic images and photographs—is likely to be a good way of helping GPs to decide which skin lesions need to be seen by a skin specialist but future research needs to be better designed.
  • Artificial intelligence techniques, such as computer-assisted diagnosis (CAD), can identify more melanomas than doctors using dermoscopy images. However, CAD systems also produce far more false positive diagnoses than dermoscopy and could lead to considerable increases in unnecessary surgery.
  • Further research is needed on the use of specialist tests such as reflectance confocal microscopy (RCM) - a non-invasive imaging technique, which allows a clinician to do a 'virtual biopsy' of the skin and obtain diagnostic clues while minimising unnecessary skin biopsies. RCM is not currently widely used in the UK but the evidence suggests that RCM may be better than dermoscopy for the diagnosis of melanoma in lesions that are difficult to diagnose.
  • Other tests such as using high frequency ultrasound have some promise, particularly for the diagnosis of BCCs, but the evidence base is small and more work is needed.

Cochrane Skin Group founder Professor Hywel Williams, of the Centre of Evidence-Based Dermatology at the University of Nottingham, said: "Completing this broad suite of detailed reviews was a real marathon.

"Apart from a few exceptions, I was surprised by how poor the overall study designs were, especially in terms of accurately documenting where on the clinical pathway patients were tested.

"Although some useful conclusions have emerged, for example, on the role of dermoscopy, the greatest value of the research is to serve as a yardstick for designing future studies evaluating skin cancer diagnosis techniques on patients who are typically seen in GP and specialist settings."

The research team said that future studies evaluating diagnostic skin tests should recruit patients with suspicious lesions at the point on the clinical pathway where the test under evaluation will be used in practice.

Further research is also needed to evaluate whether checklists to assist diagnosis by visual inspection alone can improve accuracy and to identify how much accuracy varies according to the level of expertise of the clinician carrying out the assessment.

Well-designed studies of dermoscopy in are needed, and the best ways of delivering dermoscopy training need to be identified.

The reviews have been shared with The National Institute for Health and Care Excellence (NICE) to inform a potential update of the NICE Melanoma guideline, which was last updated in 2015.

Explore further: Melanoma detection

More information: Cochrane Library (2018). www.cochranelibrary.com/collec … 651858.SC000033/full

Related Stories

Melanoma detection

December 4, 2018
Melanoma is a type of skin cancer, it is the most lethal of the various forms of this disease. It can be cured but only if detected early enough in its progress. Now, writing in the International Journal of Advanced Intelligence ...

Images increase accuracy of skin cancer self-detection

June 21, 2013
(HealthDay)—Visual images such as those of benign and cancerous skin lesions increase awareness and accuracy of skin self-examination, according to a review published in the July issue of the Journal of the American Academy ...

Reflectance confocal microscopy best IDs melanoma on head, neck

September 5, 2016
(HealthDay)—Reflectance confocal microscopy (RCM) best identifies skin cancer lesions on the head and neck, and RCM morphologic patterns differ for distinct melanomas, according to two studies published online Aug. 31 in ...

Man against machine: AI is better than dermatologists at diagnosing skin cancer

May 28, 2018
Researchers have shown for the first time that a form of artificial intelligence or machine learning known as a deep learning convolutional neural network (CNN) is better than experienced dermatologists at detecting skin ...

PAs may have lower diagnostic accuracy for melanoma

April 20, 2018
(HealthDay)—Physician assistants (PAs) perform more skin biopsies per case of skin cancer diagnosed and diagnose fewer melanomas in situ than dermatologists, according to a study published online April 18 in JAMA Dermatology.

A new blood test could detect early stage melanoma in more than 80% of patients

July 18, 2018
Melanoma kills more than 1,700 Australians every year, which is more than the national road toll. But the good news is it's treatable if caught early enough. And a new blood test might be able to help with faster and easier ...

Recommended for you

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

An integrated approach to finding new treatments for breast cancer

December 12, 2018
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Anonym518498
not rated yet Dec 06, 2018
unfortunately neither is the microscope

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.